Atara Biotherapeutics Inc.

ATRA | NASDAQ

Price Alert Chart Builder DCF Calculator

$8.01

-$0.52 (-6.10%)

At close: Oct 30, 2026, 4:00 PM ET

$8.01

$0.00 (0.00%)

Pre-market: Nov 2, 2026, 4:27 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
Net Income	32.69M	-85.4M	-276.13M	-228.3M	-340.14M	-306.62M
Depreciation & Amortization	2.38M	5.05M	4.83M	5.65M	9.35M	8.33M
Stock-Based Compensation	9.75M	27M	45.39M	53.84M	53.87M	51.35M
Other Working Capital	-111.38M	-59.84M	20.48M	-11.44M	39.91M	67M
Other Non-Cash Items	8.98M	15.59M	17.59M	-40.15M	2.04M	1.54M
Deferred Income Tax	n/a	n/a	n/a	n/a	1.79M	958K
Change in Working Capital	-104.74M	-30.96M	15.34M	-61.47M	52.58M	63.69M
Operating Cash Flow	-50.94M	-68.72M	-192.98M	-270.43M	-220.52M	-180.76M
Capital Expenditures	n/a	-246K	-1.22M	-4.19M	-10.58M	-4.51M
Cash Acquisitions	948K	n/a	n/a	n/a	-32.84M	116.22M
Purchase of Investments	-7.89M	-19.67M	-83.65M	-180.59M	-301.13M	-425.87M
Sales Maturities Of Investments	25.09M	28.54M	208.71M	292.97M	333.97M	309.65M
Other Investing Acitivies	n/a	n/a	25K	94.77M	32.84M	-116.22M
Investing Cash Flow	18.15M	8.62M	123.87M	202.96M	22.26M	-120.73M
Debt Repayment	-250K	-892K	-947K	-518K	-254K	-389K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-1K	223K	821K	31.71M	5.5M	4.99M
Financial Cash Flow	16.1M	59.28M	2.01M	53.08M	103.94M	427.57M
Net Cash Flow	-16.69M	-811K	-67.1M	-14.39M	-94.32M	126.09M
Free Cash Flow	-50.94M	-68.96M	-194.2M	-274.62M	-231.1M	-185.27M
Adj. Free Cash Flow	-60.69M	-95.96M	-239.59M	-328.46M	-284.97M	-236.62M
Maintenance CapEx	n/a	n/a	-1.22M	n/a	n/a	-4.51M
Growth CapEx	n/a	-246K	n/a	-4.19M	-10.58M	n/a
Owner Earnings	-50.94M	-68.72M	-194.2M	-270.43M	-220.52M	-185.27M